Treatment with dalbavancin in a patient with septic thrombophlebitis of the internal jugular vein due to Staphylococcus aureus after insertion of an implantable cardioverter defibrillator

Enferm Infecc Microbiol Clin (Engl Ed). 2018 Jun-Jul;36(6):389-390. doi: 10.1016/j.eimc.2017.10.002. Epub 2017 Nov 11.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Bacteremia / etiology
  • Bacteremia / microbiology
  • Defibrillators, Implantable / adverse effects
  • Defibrillators, Implantable / microbiology*
  • Humans
  • Jugular Veins / diagnostic imaging
  • Jugular Veins / microbiology*
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / microbiology
  • Pulmonary Embolism / etiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus
  • Teicoplanin / administration & dosage
  • Teicoplanin / analogs & derivatives*
  • Teicoplanin / therapeutic use
  • Thrombophlebitis / diagnostic imaging
  • Thrombophlebitis / etiology*
  • Thrombophlebitis / microbiology

Substances

  • Anti-Bacterial Agents
  • Teicoplanin
  • dalbavancin